Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.345
Peer-review started: April 23, 2021
First decision: June 7, 2021
Revised: June 21, 2021
Accepted: July 5, 2021
Article in press: July 5, 2021
Published online: August 16, 2021
Processing time: 110 Days and 9 Hours
Percutaneous gallbladder drainage has been the standard treatment of acute cholecystitis in patients who are not surgical candidates. Our study sought to evaluate the efficacy and safety of transpapillary drainage for acute cholecystitis in this subset of patients.
The key topics of interest include non-surgical, less-invasive techniques to treat acute cholecystitis. The evolution of safe and effective treatments in acute cholecystitis can lead to improved patient outcomes and quality of life following treatment. Future research can also have a positive effect on cost effectiveness and health care utilization.
The main objectives were to evaluate feasibility, efficacy and safety of transpapillary gallbladder drainage in inoperable patients for the treatment of acute cholecystitis. This can positively affect further research and direct comparison trials.
A systematic review was performed followed by updated meta-analysis.
The pooled technical success rate of endoscopic transpapillary gallbladder drainage (ETGBD) was 82.62% [95% confidence interval (CI): 80.63-84.52]. The pooled clinical success rate was found to be 94.87% (95%CI: 93.54-96.05). The pooled overall complication rate was 8.83% (95%CI: 7.42-10.34). Pooled rates of post procedure adverse events were bleeding 1.03% (95%CI: 0.58-1.62), perforation 0.78% (95%CI: 0.39-1.29), peritonitis/bile leak 0.45% (95%CI: 0.17-0.87), and pancreatitis 1.98% (95%CI: 1.33-2.76). The pooled rates of stent occlusion and migration were 0.39% (95%CI: 0.13-0.78) and 1.3% (95%CI: 0.75-1.99) respectively. The pooled rate of cholecystitis recurrence following ETGBD was 1.48% (95%CI: 0.92-2.16).
Our results demonstrated that transpapillary gallbladder drainage for treatment of acute cholecystitis is both an efficacious and safe procedure in patients that are inoperable. This particular method of gallbladder drainage may offer an alternative to a certain subset of inoperable patients who are otherwise not candidates for percutaneous drainage. Patients who demonstrate signs of concomitant choledocholithiasis or cholangitis also benefit. Comparison between percutaneous drainage, and endoscopic drainage methods with endoscopic ultrasound or a transpapillary approach has been explored however results remain inconclusive.
Future research should involve randomized controlled trials to compare the different non-surgical techniques used in treatment of acute cholecystitis. In regards to ETGBD, emphasis should be placed on different stenting methods, along with assessment of long term outcomes.